Antidepressant dose, age, and the risk of deliberate self-harm.
about
Interventions for self-harm in children and adolescentsSuicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reportsEfficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysisSelective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort StudyMethodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.Predicting persistence to antidepressant treatment in administrative claims data: Considering the influence of refill delays and prior persistence on other medications.'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed dosesSuicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort studyThe role of 5-HT1A receptors in mediating acute negative effects of antidepressants: implications in pediatric depression.Suicide Behavior Before and After the Start with Antidepressants: A High Persistent Risk in the First Month of Treatment Among the YoungDosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box WarningPoor guideline adherence in the initiation of antidepressant treatment in children and adolescents in the Netherlands: choice of antidepressant and dose.Management of treatment-resistant depression in children and adolescents.Treatment Emergent Suicidal Ideation in depressed older adults.Comparing episodes of antidepressants use with intermittent episodes of no use: A higher relative risk of suicide attempts but not of suicide at young age.SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM.Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders.Beta-adrenergic enhancement of neuronal excitability in the lateral amygdala is developmentally gated.
P2860
Q24187033-7270551A-736A-4B31-8BF9-1AEF8F4CE96AQ26773320-547AE106-F915-4E4F-A3BF-6B579121ACEDQ26824097-52162287-C320-4FF4-8671-59344F14C4BCQ28548023-6F860D5F-140B-41E5-B3D8-4BF901A7E34AQ30966054-B391BECB-277D-4098-B983-CE6F8E81A25CQ31049668-E1D129BD-2886-4F47-B35E-0D2946715926Q33808307-76BF237E-06C8-4C1D-BC9C-726142CFE958Q35129198-6A8B7D52-B530-491C-9234-0592E04057E6Q35753190-2D8A6105-195E-4FBF-8796-6FFBC542777CQ36635612-62235EDB-7E00-4A72-91B8-DDA6EC038802Q37275848-CE85E0F8-9192-4F07-B552-AAEB35A3401CQ37373205-9CC3CE5C-2801-4198-8851-C459BCD59D75Q38247062-F284BE03-7C98-45D1-A52F-C7F07DD0A722Q39780546-C6D0E3A3-6720-4446-B46A-26F44708EC31Q40838252-917B02F8-2287-4BAD-914A-E7334C34E0CBQ48063920-98D020CE-56CE-4077-9FCD-F893C2806FCDQ48075180-FD8493E6-F0A1-4CEC-90BA-271303A0435BQ50423619-55A7CCC1-EBDF-452B-B276-4B99B32CD70E
P2860
Antidepressant dose, age, and the risk of deliberate self-harm.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antidepressant dose, age, and the risk of deliberate self-harm.
@ast
Antidepressant dose, age, and the risk of deliberate self-harm.
@en
Antidepressant dose, age, and the risk of deliberate self-harm.
@nl
type
label
Antidepressant dose, age, and the risk of deliberate self-harm.
@ast
Antidepressant dose, age, and the risk of deliberate self-harm.
@en
Antidepressant dose, age, and the risk of deliberate self-harm.
@nl
prefLabel
Antidepressant dose, age, and the risk of deliberate self-harm.
@ast
Antidepressant dose, age, and the risk of deliberate self-harm.
@en
Antidepressant dose, age, and the risk of deliberate self-harm.
@nl
P2093
P1476
Antidepressant dose, age, and the risk of deliberate self-harm.
@en
P2093
Deborah Azrael
Matthew Miller
Sonja A Swanson
P304
P356
10.1001/JAMAINTERNMED.2014.1053
P577
2014-06-01T00:00:00Z